How to facilitate early diagnosis of CNS involvement in malignant lymphoma

Radio-OncologyLymphoma

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

Br J Haematol.

Wight JC, Yue M, Keane C, Johnston A, Linton K, Chin C, Wai SH, Talaulikar D, Gasiorowski R, Yoon Cheah C, Gregory GP, Dickinson M, Minson A, Coombes C, Ku M, Lam S, Hawkes EA

doi: 10.1111/bjh.16064.

Lymphoma

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

Lancet Haematol

Ferreri AJM, Doorduijn JK, Re A, Cabras MG, Smith J, Ilariucci F, Luppi M, Calimeri T, Cattaneo C, Khwaja J, Botto B, Cellini C, Nassi L, Linton K, McKay P, Olivieri J, Patti C, Re F, Fanni A, Singh V, Bromberg JEC, Cozens K, Gastaldi E, Bernardi M, Cascavilla N, Davies A, Fox CP, Frezzato M, Osborne W, Liberati AM, Novak U, Zambello R, Zucca E, Cwynarski K, International Extranodal Lymphoma Study Group (IELSG).

doi: 10.1016/S2352-3026(20)30366-5

Lymphoma

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review

Br J Haematol.

van Westrhenen A, Smidt LCA, Seute T, Nierkens S, Stork ACJ, Minnema MC, Snijders TJ

doi: 10.1111/bjh.15410.

Lymphoma

Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management

Am J Hematol.

Ansell SM

doi: 10.1002/ajh.25856.

Lymphoma

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

Am J Hematol.

Ansell SM

doi: 10.1002/ajh.25071.

Lung, Respiratory and Thoracic CancerMultiple Myeloma (MM)

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Arch Pathol Lab Med.

Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR

doi: 10.5858/arpa.2017-0124-RA.

Lymphoma

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

Haematologica.

Seymour JF, Marcus R, Davies A, Gallop-Evans E, Grigg A, Haynes A, Herold M, Illmer T, Nilsson-Ehle H, Sökler M, Dünzinger U, Nielsen T, Launonen A, Hiddemann W

doi: 10.3324/haematol.

Gynecologic Cancer

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Gynecol Oncol.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F

doi: 10.1016/j.ygyno.2017.07.139.

Lymphoma

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

Lancet Haematol

Gillessen S, Plütschow A, Fuchs M, Markova J, Greil R, Topp MS, Meissner J, Zijlstra JM, Eichenauer DA, Bröckelmann PJ, Diehl V, Borchmann P, Engert A, von Tresckow B

doi: 10.1016/S2352-3026(21)00029-6

Related content

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review

Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)